This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2000 Dec;30(3):211-4.

doi: 10.1016/s0169-5002(00)00211-7.

Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: a tool for early diagnosis?

G Cuda, A Gallelli, A Nisticò, P Tassone, V Barbieri, P S Tagliaferri, F S Costanzo, C M Tranfa, S Venuta

PMID: 11147802
DOI: 10.1016/s0169-5002(00)00211-7

Clinical Trial

Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: a tool for early diagnosis?

G Cuda et al. Lung Cancer. 2000 Dec.

. 2000 Dec;30(3):211-4.

doi: 10.1016/s0169-5002(00)00211-7.

Authors

G Cuda, A Gallelli, A Nisticò, P Tassone, V Barbieri, P S Tagliaferri, F S Costanzo, C M Tranfa, S Venuta

PMID: 11147802
DOI: 10.1016/s0169-5002(00)00211-7

No abstract available

PubMed Disclaimer

Similar articles

Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
Sozzi G, Musso K, Ratcliffe C, Goldstraw P, Pierotti MA, Pastorino U. Sozzi G, et al. Clin Cancer Res. 1999 Oct;5(10):2689-92. Clin Cancer Res. 1999. PMID: 10537330
Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
Froudarakis ME, Sourvinos G, Fournel P, Bouros D, Vergnon JM, Spandidos DA, Siafakas NM. Froudarakis ME, et al. Chest. 1998 Apr;113(4):1091-4. doi: 10.1378/chest.113.4.1091. Chest. 1998. PMID: 9554652
Fractional allele loss is a valuable marker for human lung cancer detection in sputum.
Arvanitis DA, Papadakis E, Zafiropoulos A, Spandidos DA. Arvanitis DA, et al. Lung Cancer. 2003 Apr;40(1):55-66. doi: 10.1016/s0169-5002(02)00531-7. Lung Cancer. 2003. PMID: 12660007
Molecular pathology of non-small-cell lung cancer.
Breuer RH, Postmus PE, Smit EF. Breuer RH, et al. Respiration. 2005 May-Jun;72(3):313-30. doi: 10.1159/000085376. Respiration. 2005. PMID: 15942304 Review.
Molecular genetic characteristics of lung cancer--useful as real' tumor markers?
Fleischhacker M, Beinert T, Possinger K. Fleischhacker M, et al. Lung Cancer. 1999 Jul;25(1):7-24. doi: 10.1016/s0169-5002(99)00043-4. Lung Cancer. 1999. PMID: 10466858 Review.

See all similar articles

Cited by

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA).
Kimura H, Suminoe M, Kasahara K, Sone T, Araya T, Tamori S, Koizumi F, Nishio K, Miyamoto K, Fujimura M, Nakao S. Kimura H, et al. Br J Cancer. 2007 Sep 17;97(6):778-84. doi: 10.1038/sj.bjc.6603949. Br J Cancer. 2007. PMID: 17848912 Free PMC article.
Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, Zhu RM, Li GL, Xia XY, Wei XW, Ji HZ, Lu H, Gao Y, Gao WM, Chen LB. Wang YC, et al. World J Gastroenterol. 2008 May 21;14(19):3074-80. doi: 10.3748/wjg.14.3074. World J Gastroenterol. 2008. PMID: 18494062 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information